Orthopedic Joint Replacement Market Size, Share & COVID-19 Impact Analysis, By Product (Knee, Hip, Shoulder, Ankle, and Others), By Procedure (Total, Partial, and Others), By End user (Hospitals & ASCs, Orthopedic Clinics, and Others) and Regional Forecast, 2023-2030

The orthopedic joint replacement market size was valued at USD 20.80 billion in 2022 and is projected to grow USD 22.28 billion in 2023 to USD 37.99 billion by 2030, exhibiting a CAGR of 7.9% during 2023-2030. North America dominated the global market with a share of 35.86% in 2022.

Osteoarthritis is one of the most prevalent diseases among the geriatric population. Joint replacement has emerged as the most popular option for the treatment of osteoarthritis, which has resulted in a wider acceptance of joint implants among patients. A notable rise in the geriatric population is supplementing the orthopedic joint replacement market growth due to the increasing incidence of hip fractures in the elderly population. According to an article published in Agappe in November 2022, 260,000 to 300,000 individuals are estimated to be hospitalized each year for hip fractures in the U.S. By 2040, the number is estimated to reach 500,000.

With the introduction of robotic surgery and patient-specific 3D printed implants, the demand for orthopedic joint replacement implants has drastically increased, which is further augmented by support from regulatory bodies. For instance, in April 2023, Moximed received the marketing approval for its MISHA Knee System. This product is aimed at helping people effectively manage knee osteoarthritis. The market is also being favored by active government support and patient-friendly health reimbursement policies.

COVID-19 IMPACT

Decline in Orthopedic Surgeries amid COVID-19 Hindered Market Growth

Declines, delays, or cancellations in elective surgeries, such as those for orthopedic joint replacement had a huge impact on the global market growth. According to the CJRR Annual Report 2020-2021, the number of knee and hip replacement surgeries in Canada decreased by 26.4% and 12.9% respectively during 2020-21. This was mainly due to the cancellation of planned surgeries owing to COVID-19 related restrictions.

Moreover, according to GlobalSurg, the estimated volume of normal elective orthopedic surgeries during March 2020 – May 2020 should have been around 7.7 million. However, the pandemic led to an 82% cancellation of these surgeries during the peak period. Additionally, the U.K.’s National Health Service (NHS) had directed all hospitals in England to postpone non-urgent elective procedures for 3 months starting from April 15.

Due to the COVID-induced lockdowns, the pharma sector witnessed disruptions in supply chains due to the limitations on imports & exports, closure of flights, reduced production, and disturbed supply channels. The market was anticipated to witness a surge in 2021, and is expected to grow steadily during the forecast period.

LATEST TRENDS

Increasing Adoption of Online Tools to Gain Orthopedic Knowledge Will Open New Market Growth Avenues

With the rapid proliferation of the internet, patients have been referring to web-based tools and online resources to obtain information about specific diseases. Orthopedic joint replacement is one such area witnessing the introduction of a number of online tools guiding patients through their surgeries, connecting with the orthopedic surgeons, and providing post-surgery rehabilitation information.

• For instance, in January 2021, Ortoma AB introduced an Artificial Intelligence-based software platform to help in implant procedures by improving surgery accuracy. The product received approvals from both the U.S. and Europe.

ORTHOPEDIC JOINT REPLACEMENT MARKET GROWTH FACTORS

Technological Innovations in Orthopedic Implants to Augment Market Growth

The market growth is expected to get a boost in the form of increasing demand for customized joint implants for both males and females. Since each patient has a unique anatomy, the concept of “one size fits all” is not applicable, and hence major medical device companies are striving to leverage advanced technologies to manufacture patient-specific orthopedic implants. For instance, in November 2022, ConforMIS Inc. introduced Imprint Knee System in the U.S. With this, the company also introduced a “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA).

Furthermore, the introduction of 3D printing technology to manufacture orthopedic implants has resulted in a huge surge in demand for customized implants. Many orthopedic device companies are developing cutting-edge technologies that can be used to supply advanced joint implants, which is likely to favor the market growth during the projected timeframe.

Advancements in Robotic Surgeries to Boost Demand for Joint Replacement Devices

The adoption of surgical robots in the field of orthopedics has increased the efficiency of surgical procedures and thus, many hospitals are now offering robotic surgeries for the treatment of various orthopedic diseases. Several manufacturers are focusing on developing surgical robots that can be used in spinal fusion surgeries along with the company’s implants and navigation tools.

For instance, in November 2021, Smith+Nephew introduced CORI handheld robotics to assist in both total and partial knee arthroplasties. This advanced system is designed to enhance the skill sets of the orthopedic team. Additionally, in January 2019, Medtronic announced the launch of Mazor X Stealth Edition, a robotic system for spine surgery. The system can be used with the company’s spinal implants and navigation & 3D imaging tools, providing a comprehensive solution to healthcare professionals.

RESTRAINING FACTORS

Product Recalls and Lawsuits on Orthopedic Devices to Hamper Market Growth

The volume of orthopedic joint replacement surgeries is increasing exponentially. However, complications associated with the use of the implants are a major factor that is anticipated to hamper the growth of the market in the coming years.

Additionally, product recalls of knee and hip replacement devices by major players around the globe are also estimated to hinder the growth of the market. According to the U.S. Food and Drug Administration (FDA), from 2003 to 2019 there were more than 13,000 recalls of knee replacement components and systems. The highest number of recalls was recorded by Zimmer Biomet, followed by Johnson and Johnson Services Inc., and Smith & Nephew.

SEGMENTATION ANALYSIS

By Product Analysis

Knee Segment to Hold Dominating Position Owing to High Number of Procedures 

On the basis of product, the market is categorized into knee, hip, shoulder, ankle, and others. The knee segment dominated the orthopedic joint replacement market share in 2022. Increase in the number of knee replacement procedures, which include total knee replacement procedures, robot-assisted knee replacement surgeries, and launch of products, such as ATTUNE Revision Knee System, Persona Partial Knee System, JOURNEY II XR Total Knee by key manufacturers are the factors responsible for the strong growth of the knee segment during the forecast period. For instance, in January 2022, Symbios Orthopédie S.A. launched the ORIGIN CR Total Knee System. This system allows surgeons to proceed with custom-made knee replacement surgery preserving the Posterior Cruciate Ligament (PCL).

Furthermore, the rapidly increasing prevalence of chronic knee-related diseases has boosted the number of knee replacement surgeries being performed across the world. For instance, according to the American Joint Replacement Registry 2022 Annual Report, the number of knee arthroplasty procedures between 2012 and 2021 had reached 1,495,965.

The shoulder segment is projected to register a strong growth rate owing to the shifting focus of manufacturers toward shoulder implants. Also, rapid increase in the number of shoulder replacement surgeries performed globally is anticipated to boost the sales of shoulder implants during the forecast period. For instance, according to a study published in the NCBI in November 2021, the number of primary shoulder replacement surgeries was estimated to grow significantly in the coming years, reaching at least 37,000 procedures per year.

By Procedure Analysis

Total Replacement Captured Majority Market Share Owing to High Number of Product Offerings

In terms of procedure, the market is categorized into total replacement, partial replacement, and others. The total replacement segment accounted for the maximum market share in 2022 owing to a higher number of product offerings for total orthopedic joint replacement procedures as compared to that for partial, reverse, or revision replacement.

The partial replacement segment is anticipated to report a remarkable CAGR, which can be attributed to the increased preference for partial replacement over total replacement among patients and healthcare providers.

By End User Analysis

High Procedure Volume in Hospitals & ASCs Resulted in Segment’s Dominance in the Market

On the basis of end user, the market has been segmented into hospitals & ASCs, orthopedic clinics, and others. Among these, the hospital & ASC segment dominated the global market in 2022. Factors, such as the growing number of hip implant surgeries within these facilities are contributing to the segment’s growth. Hospitals are generally equipped with the latest technologies and skilled healthcare professionals, which is further boosting the segment’s growth. For instance, in October 2023, Apollo Institute of Orthopedics completed 370 robotic knee replacement procedures over a period of 10 months since the launch of these surgeries in January 2022.

Furthermore, collaborations between hospitals and industry players to create advanced surgical procedures are also fostering the segment’s growth. According to the American Joint Replacement Registry’s 2021 annual report, the total number of joint replacement surgeries in ASCs increased by 55% in 2020. Such data indicates an increasing number of joint replacement surgeries being performed in ASCs.

The orthopedic clinics segment is also anticipated to register a considerable CAGR throughout the forecast period. This is attributed to the increasing number of orthopedic clinics in areas where access to medical facilities is limited.

REGIONAL INSIGHTS

North America dominated the market share with a revenue of USD 7.46 billion in 2022 and will continue to dominate the market throughout the forecast period. Factors, such as growing awareness among the patient population regarding technologically advanced orthopedic implants and new treatment options available in the region are responsible for the region’s dominance in the global market. Furthermore, the increasing demand for hip replacement surgeries in the U.S. is contributing to the regional market growth. For example, according to the Agency for Healthcare Research and Quality, more than 450,000 total hip replacement procedures are performed each year in the U.S.

The growth of the market in Europe is attributed to the increasing prevalence of osteoarthritis, growing demand for orthopedic joint replacement implants, and rising day-care surgeries. For instance, according to an article published by NICE in October 2022, about 18% of the U.K. population aged over 45 years had sought treatment for knee-related osteoarthritis. This shows high prevalence of the disease in the country. Furthermore, an increase in healthcare expenditure by the European Commission is anticipated to fuel the growth of the market in the region.

The market in Asia Pacific is expected to record the highest CAGR during the forecast duration. Factors, such as a large patient pool and growing healthcare spending are supplementing the market growth in Asia Pacific. Moreover, increasing adoption of advanced products supplemented the market growth. For instance, in February 2023, Criticare Asia Hospital in Mumbai, India successfully completed the first partial knee replacement surgery using fully automated robotic arm technology.

Technological advancements, expansion of distribution networks of key players in emerging economies, and increasing healthcare spending are some of the primary factors augmenting the market growth in Latin America and the Middle East & Africa.

KEY INDUSTRY PLAYERS

Consolidated Market Structure to Enable Few Key Players to Hold Dominant Position

Zimmer Biomet, Stryker, Johnson & Johnson Services, Inc., and Smith & Nephew are the prominent players in the market and captured a considerable share of the global market in 2022. The dominance of these players can be attributed to their diversified portfolios of joint implants for both upper and lower extremities. These companies are actively engaged in new product launches to maintain their market dominance. For instance, in March 2023, Smith + Nephew showcased its Orthopedics Arthroplasty portfolio at the AAOS 2023 Annual Meeting. The company unveiled a franchise-level value proposition named “Precision in Motion” for its robust portfolio.

Furthermore, Johnson & Johnson Services, Inc. and Stryker, together with their knee and hip implant portfolios, hold a major position in the market. Other players operating in the market are B. Braun Melsungen AG, Bioimpianti, Conformis, MicroPort Scientific Corporation, and other players.

LIST OF KEY COMPANIES IN ORTHOPEDIC JOINT REPLACEMENT MARKET:

• Stryker (U.S.)


• Johnson & Johnson Services, Inc. (U.S.)


• Smith + Nephew (U.K.)


• Zimmer Biomet (U.S.)


• B. Braun Melsungen AG (Germany)


• Bioimpianti (Italy)


• Conformis (U.S.)


• MicroPort Scientific Corporation (China)


• Enovis (U.S.)         

KEY INDUSTRY DEVELOPMENTS:

• November 2022: An orthopedic surgeon from Australia performed the first 3D-printed, custom knee replacement surgery in regional Victoria. This was a U.S.-made technology which has become available in Australia since March 2022.


• July 2022: Enovis launched a wearable, self-contained surgical guidance device named Arvis for orthopedic navigation. The Augmented Reality visualization and information system is aimed at helping surgeons with precision guidance visualization.


• September 2020: Stryker announced the launch of Mako Total Hip 4.0 for robotic hip replacement surgeries. The new software will help a physician plan a patient’s hip implant position based on their sitting, standing, and supine poses.


• August 2019: Globus Medical acquired StelKast, a leading manufacturer of knee and hip implants, to expand its product portfolio.


• February 2019: Colfax Corporation completed the acquisition of DJO, which would strengthen the company’s position in the joint replacement market.

REPORT COVERAGE

The market report provides qualitative and quantitative insights on the joint replacement industry and a detailed analysis of the market size and growth rate for all possible segments. Along with this, the report provides an elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are the number of joint replacement procedures performed in key countries, new product launches, regulatory scenario & overview of reimbursement policies in key countries, recent industry developments, such as mergers & acquisitions, and key industry trends.

Report Scope & Segmentation